BackPureTech Health plc Overview
PureTech Health plc

PureTech Health plc Return on Equity

Latest ROE for PureTech Health plc: 13.5% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

13.50%

Return on Equity

13.50%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

PureTech Health plc (PRTCY) FAQ

The latest ROE for PRTCY is 13.5%. That is below the Finance sector average of 20.27%. Investors often review this figure alongside PureTech Health plc's historical trend and sector peers before judging valuation or financial health.

Against Finance companies, PRTCY currently prints 13.5% for ROE, while the sector average sits near 20.27%. That is roughly 33.4% below the sector mean. Large gaps often invite a closer look at PureTech Health plc's growth, margins, and balance sheet.

Return on Equity shows how effectively PureTech Health plc converts resources into returns. At 13.5%, PRTCY may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting PRTCY's ROE (13.5%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack PureTech Health plc's ROE against similar Finance names. You can also browse sector and industry screens on Stockcircle for a broader set of Finance companies and their key multiples and fundamentals.